HY-100748-1mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
HY-100748-10mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
HY-100748-100mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
HY-100748-5mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
HY-100748-50mg
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3]
|
|
Cancer-programmed cell death
|
|
HY-117997-1mg
|
MedChemexpress LLC
|
UMB-32 [CAS 1635437-39-6]
|
|
Cancer-programmed cell death
|
|
HY-17473-10mg
|
MedChemexpress LLC
|
Embelin [CAS 550-24-3]
|
|
Cancer-programmed cell death
|
|
HY-17473-5mg
|
MedChemexpress LLC
|
Embelin [CAS 550-24-3]
|
|
Cancer-programmed cell death
|
|
HY-17473-50mg
|
MedChemexpress LLC
|
Embelin [CAS 550-24-3]
|
|
Cancer-programmed cell death
|
|
HY-50935-10mg
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7]
|
|
Cancer-programmed cell death
|
|
HY-50935-100mg
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7]
|
|
Cancer-programmed cell death
|
|
HY-50935-5mg
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7]
|
|
Cancer-programmed cell death
|
|
HY-50935-50mg
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7]
|
|
Cancer-programmed cell death
|
|
HY-50935S-1mg
|
MedChemexpress LLC
|
Troglitazone-d4 [CAS 2749370-85-0]
|
|
Cancer-programmed cell death
|
|
HY-100748-1mL
|
MedChemexpress LLC
|
Zabadinostat [CAS 934828-12-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-17473-1mL
|
MedChemexpress LLC
|
Embelin [CAS 550-24-3] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
HY-50935-1mL
|
MedChemexpress LLC
|
Troglitazone [CAS 97322-87-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|